Skip to content

Language: Japanese

DFI Displays its Mobility with their First Win of the 2022 Taiwan Corporate Sustainability Award

By asianet

In recent years, DFI, the world leading brand in embedded motherboards and industrial computers, has actively implemented corporate sustainable management. In addition to producing a sustainability report this year, the company also signed up for the “2022 15th Taiwan Corporate Sustainability Award (TCSA)”, winning the “Corporate Sustainability Report Category – Electronics and IT Manufacturing Bronze … Continued

SILVERSEA CRUISES PRESIDENT AND CEO ROBERTO MARTINOLI TRANSITIONS TO SENIOR ADVISOR ROLE; BARBARA MUCKERMANN NAMED TO SUCCEED HIM

By asianet

–Martinoli to assume senior advisor role to Royal Caribbean Group President and CEO Jason Liberty, after building Silversea Cruises into the world’s leading ultra-luxury cruise line Silversea Cruises President and CEO Roberto Martinoli has elevated the brand into the industry’s leading ultra-luxury cruise line. On January 1, 2023, Martinoli will assume the role of senior … Continued

Accor’s list of top 2023 hotel openings

By asianet

— A SNAPSHOT OF “COMING SOON” PROPERTIES FROM THE WORLD’S MOST PARIS, Dec. 15, 2022 /PRNewswire-AsiaNet/ — As buzz and anticipation builds around 2023 travel planning, Accor is pleased to reveal a short list of highly anticipated properties to open next year. From city breaks to beach getaways, from eco-minded or budget-friendly hotels to ultra-luxurious … Continued

Pharming announces positive interim analysis data from open-label extension study of leniolisib in presentation at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition

By asianet

V. Koneti Rao, MD, shared new evidence of long-term safety and hematologic response in patients who received leniolisib to treat APDS, a rare primary immunodeficiency Interim analysis demonstrated leniolisib to be well tolerated and indicated the durability of the efficacy results seen in the Phase II/III randomized, controlled trial Pharming Group N.V. (“Pharming” or “the … Continued

Novavax Announces Proposed $125 Million Public Offering of Common Stock

By asianet

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced a proposed underwritten public offering to sell up to $125 million of its common stock. In connection with the common stock offering, Novavax expects to grant to the underwriters a 30-day option to purchase up … Continued